Eli Lilly and Company

NYSE:LLY 株式レポート

時価総額:US$801.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Eli Lilly 過去の業績

過去 基準チェック /26

Eli Lillyは、平均年間6.6%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 減少しています。収益は、平均年間0.4% 9.5%収益成長率で 成長しています。 Eli Lillyの自己資本利益率は47.6%であり、純利益率は17.1%です。

主要情報

6.6%

収益成長率

7.6%

EPS成長率

Pharmaceuticals 業界の成長6.0%
収益成長率9.5%
株主資本利益率47.6%
ネット・マージン17.1%
次回の業績アップデート08 Aug 2024

最近の業績更新

Recent updates

Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis)

Jun 24

Eli Lilly And Alzheimer's Disease: The Paucity Of Progress

Jun 17

Eli Lilly Continues To Climb As Alzheimer's Drug Gains FDA Approval

Jun 11

These 4 Measures Indicate That Eli Lilly (NYSE:LLY) Is Using Debt Reasonably Well

Jun 10
These 4 Measures Indicate That Eli Lilly (NYSE:LLY) Is Using Debt Reasonably Well

Eli Lilly's Growth And Challenges: A Cautious Buy

Jun 01

Eli Lilly: Addressing Supply Challenges Should Accelerate Growth

May 26

Eli Lilly: Bloated Stock

May 01

What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S

Apr 22
What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S

Wall Street Lunch: Lilly In Limelight

Apr 17

Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets

Mar 29

Eli Lilly: The Party Is Not Over

Mar 23

Estimating The Intrinsic Value Of Eli Lilly and Company (NYSE:LLY)

Mar 17
Estimating The Intrinsic Value Of Eli Lilly and Company (NYSE:LLY)

Eli Lilly: Yes, It Is Too Late To Join The Party

Feb 20

Eli Lilly: Overvaluation Is A Big Red Flag

Feb 14

Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade)

Feb 07

Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value

Jan 31

Eli Lilly (NYSE:LLY) Has Announced That It Will Be Increasing Its Dividend To $1.30

Jan 24
Eli Lilly (NYSE:LLY) Has Announced That It Will Be Increasing Its Dividend To $1.30

Eli Lilly: The Cupboard Is Fully Stocked

Jan 19

Eli Lilly: The Buzz Is Not Over

Jan 11

Eli Lilly (NYSE:LLY) Is Increasing Its Dividend To $1.30

Jan 10
Eli Lilly (NYSE:LLY) Is Increasing Its Dividend To $1.30

Eli Lilly (NYSE:LLY) Is Paying Out A Larger Dividend Than Last Year

Dec 27
Eli Lilly (NYSE:LLY) Is Paying Out A Larger Dividend Than Last Year

Pinning Down Eli Lilly and Company's (NYSE:LLY) P/S Is Difficult Right Now

Dec 24
Pinning Down Eli Lilly and Company's (NYSE:LLY) P/S Is Difficult Right Now

Eli Lilly: Long Path To A Trillion

Dec 21

Eli Lilly (NYSE:LLY) Has A Pretty Healthy Balance Sheet

Dec 05
Eli Lilly (NYSE:LLY) Has A Pretty Healthy Balance Sheet

Bubble Warning: Unrealistic Growth Priced In And Multiple Risk Factors For Eli Lilly

Nov 30

収支内訳

Eli Lilly の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NYSE:LLY 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 2435,9326,1387,1449,851
31 Dec 2334,1245,2406,9419,313
30 Sep 2332,0734,9886,6828,747
30 Jun 2329,5166,4986,5158,140
31 Mar 2327,6915,6876,2367,566
31 Dec 2228,5416,2456,0687,191
30 Sep 2229,2406,0336,0377,093
30 Jun 2229,0715,6926,0206,996
31 Mar 2229,3236,1296,1046,869
31 Dec 2128,3185,5826,1426,931
30 Sep 2127,7595,9726,1196,870
30 Jun 2126,7266,0716,0696,631
31 Mar 2125,4866,0935,8676,366
31 Dec 2024,5406,1945,8695,976
30 Sep 2023,2145,5736,0195,829
30 Jun 2022,9505,6185,9245,745
31 Mar 2023,0875,5336,0485,757
31 Dec 1922,3204,6386,0045,595
30 Sep 1921,8434,2645,9845,405
30 Jun 1921,6734,1036,0195,305
31 Mar 1921,6222,5455,9135,174
31 Dec 1821,4933,1515,7355,051
30 Sep 1822,0163725,8555,146
30 Jun 1822,368-1665,9755,205
31 Mar 1822,6071,0746,2105,207
31 Dec 1719,974-865,7335,096
30 Sep 1722,4712,2256,4755,321
30 Jun 1722,0052,4476,5265,217
31 Mar 1721,5852,1876,4835,281
31 Dec 1621,2222,7386,3305,310
30 Sep 1620,8372,4446,4605,238
30 Jun 1620,6052,4666,4715,145
31 Mar 1620,1792,3196,4834,978
31 Dec 1519,9592,4086,5334,796
30 Sep 1519,7042,3596,5354,538
30 Jun 1519,6202,0596,6314,638
31 Mar 1519,5772,1926,6594,664
31 Dec 1419,6162,3916,6214,734
30 Sep 1420,3032,6906,7755,023
30 Jun 1421,2003,3926,7555,158
31 Mar 1422,1943,8656,9595,293
31 Dec 1323,1134,6857,1265,531
30 Sep 1323,2624,7857,1505,519
30 Jun 1322,9324,9087,2555,484

質の高い収益: LLY 非現金収入 のレベルが高いです。

利益率の向上: LLYの現在の純利益率 (17.1%)は、昨年(20.5%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: LLYの収益は過去 5 年間で年間6.6%増加しました。

成長の加速: LLYの過去 1 年間の収益成長率 ( 7.9% ) は、5 年間の平均 ( 年間6.6%を上回っています。

収益対業界: LLYの過去 1 年間の収益成長率 ( 7.9% ) Pharmaceuticals業界19.9%を上回りませんでした。


株主資本利益率

高いROE: LLYの 自己資本利益率 ( 47.59% ) は 抜群 ですが、負債レベルが高いためこの指標は歪んでいます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘